| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/26/2022 | 26.23% | Piper Sandler | $96 → $85 | Maintains | Overweight |
| 08/08/2022 | 18.8% | UBS | → $80 | Upgrades | Sell → Neutral |
| 08/03/2022 | 47.02% | Barrington Research | $102 → $99 | Maintains | Outperform |
| 08/03/2022 | 33.65% | Credit Suisse | $100 → $90 | Maintains | Outperform |
| 07/21/2022 | 26.23% | Goldman Sachs | $93 → $85 | Downgrades | Buy → Neutral |
| 06/17/2022 | 18.8% | Stifel | $90 → $80 | Maintains | Hold |
| 06/14/2022 | 30.68% | Baird | $103 → $88 | Downgrades | Outperform → Neutral |
| 05/13/2022 | 48.5% | Credit Suisse | → $100 | Assumes | → Outperform |
| 02/16/2022 | 6.92% | Morgan Stanley | $67 → $72 | Maintains | Underweight |
| 02/16/2022 | 48.5% | Credit Suisse | $90 → $100 | Maintains | Outperform |
| 01/31/2022 | -0.5% | Morgan Stanley | → $67 | Initiates Coverage On | → Underweight |
| 01/07/2022 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 02/08/2021 | 23.26% | Piper Sandler | → $83 | Assumes | → Overweight |
| 01/04/2021 | 17.32% | Baird | $70 → $79 | Upgrades | Neutral → Outperform |
| 05/07/2020 | -25.75% | UBS | $60 → $50 | Maintains | Sell |
| 05/06/2020 | -10.9% | Baird | $58 → $60 | Maintains | Neutral |
| 05/05/2020 | -10.9% | CFRA | $69 → $60 | Maintains | Hold |
| 04/02/2020 | 0.98% | Wolfe Research | → $68 | Upgrades | Peer Perform → Outperform |
| 03/31/2020 | -15.35% | Barclays | $58 → $57 | Maintains | Equal-Weight |
| 02/24/2020 | 0.98% | JP Morgan | $66 → $68 | Maintains | Neutral |
| 01/02/2020 | 3.95% | Evercore ISI Group | $61 → $70 | Upgrades | Underperform → In-Line |
| 12/03/2019 | 5.44% | B of A Securities | $69 → $71 | Maintains | Neutral |
| 11/12/2019 | -16.84% | UBS | $57 → $56 | Maintains | Sell |
| 08/07/2019 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 05/15/2019 | 3.95% | SVB Leerink | $75 → $70 | Downgrades | Outperform → Market Perform |
| 04/18/2019 | 6.92% | Guggenheim | → $72 | Initiates Coverage On | → Buy |
| 02/21/2019 | -6.44% | Barclays | $73 → $63 | Maintains | Equal-Weight |
| 01/17/2019 | 8.41% | UBS | → $73 | Initiates Coverage On | → Sell |
| 01/03/2019 | — | Evercore ISI Group | Downgrades | In-Line → Underperform | |
| 01/02/2019 | — | Baird | Downgrades | Outperform → Neutral | |
| 10/25/2018 | — | Edward Jones | Downgrades | Hold → Sell | |
| 10/09/2018 | -1.99% | Morgan Stanley | $65 → $66 | Maintains | Underweight |
| 08/07/2018 | 33.65% | Baird | $83 → $90 | Maintains | Outperform |
| 08/07/2018 | 20.29% | Stifel | $76 → $81 | Maintains | Hold |
| 04/24/2018 | — | Goldman Sachs | Downgrades | Buy → Neutral | |
| 04/24/2018 | 21.77% | Deutsche Bank | $79 → $82 | Maintains | Buy |
| 04/04/2018 | — | Leerink Swann | Upgrades | Market Perform → Outperform | |
| 03/08/2018 | 5.44% | Barclays | → $71 | Initiates Coverage On | → Equal-Weight |
| 02/21/2018 | 11.38% | Leerink Swann | $77 → $75 | Maintains | Market Perform |
| 02/15/2018 | 14.35% | JP Morgan | $79 → $77 | Maintains | Neutral |
| 01/05/2018 | 20.29% | Evercore ISI Group | → $81 | Initiates Coverage On | → Outperform |
| 12/08/2017 | 17.32% | Deutsche Bank | → $79 | Initiates Coverage On | → Buy |
| 12/06/2017 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 11/28/2017 | 12.86% | Stephens & Co. | → $76 | Initiates Coverage On | → Equal-Weight |
| 11/07/2017 | 14.35% | Leerink Swann | $87.5 → $77 | Maintains | Market Perform |
| 11/07/2017 | — | Craig-Hallum | Upgrades | Hold → Buy | |
| 11/07/2017 | 9.89% | Jefferies | $89 → $74 | Maintains | Hold |
Henry Schein Questions & Answers
The latest price target for Henry Schein (NASDAQ: HSIC) was reported by Piper Sandler on September 26, 2022. The analyst firm set a price target for $85.00 expecting HSIC to rise to within 12 months (a possible 26.23% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for Henry Schein (NASDAQ: HSIC) was provided by Piper Sandler, and Henry Schein maintained their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Henry Schein, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Henry Schein was filed on September 26, 2022 so you should expect the next rating to be made available sometime around September 26, 2023.
While ratings are subjective and will change, the latest Henry Schein (HSIC) rating was a maintained with a price target of $96.00 to $85.00. The current price Henry Schein (HSIC) is trading at is $67.34, which is out of the analyst's predicted range.